Man

Soledad Mac Keon Pagliettini

Investigadora Postdoctoral

IMPACT, Universidad de los Andes

Santiago, Chile

Líneas de Investigación


Como investigadora postdoctoral de Centro Impact he estado trabajando en el desarrollo del proceso de manufactura de una terapia CAR-T para linfoma no Hodgkin.

Educación

  •  Química Biológica, Universidad de Buenos Aires. Argentina, 2014

Experiencia Profesional

  •   Investigadora Postdoctoral Full Time

    IMPACT, Universidad de los ANdes

    Santiago, Chile

    2023 - A la fecha

  •   Investigadora Postdoctoral Full Time

    Fundación Instituto Leloir

    Buenos Aires, Argentina

    2014 - 2019

  •   Investigadora Doctoral Full Time

    Fundación Instituto Leloir

    Buenos Aires, Argentina

    2009 - 2014


 

Article (5)

Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model
Phase ii Study of adjuvant immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose interferon alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: a Single institution, randomized Study
CD207<SUP>+</SUP> cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice
Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors
Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue

Review (1)

Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
6
Soledad Mac Keon

Investigadora Postdoctoral

IMPACT

IMPACT, Universidad de los Andes

Santiago, Chile